← Back to Search

Electronic Sexual Health CDS Tool for Adolescent STI Testing

N/A
Waitlist Available
Led By Brian P. Jenssen, MD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

This trial aims to develop and test a tool that will help pediatricians provide better sexual health care to adolescents, including STI testing. It'll be evaluated for effectiveness, acceptability and usability.

Who is the study for?
This trial is for pediatric clinicians using the STI Testing CDS tool, English-speaking adolescents aged 13 or older at a preventive care visit, and their parents who are over 18, speak English, have a smartphone, and contact info in the EHR.Check my eligibility
What is being tested?
The study aims to develop an STI testing clinical decision support (CDS) tool within the electronic health record. It will help clinicians with sexual health screening and referrals. Its feasibility and impact on clinical measures will be evaluated.See study design
What are the potential side effects?
Since this trial involves an informational tool rather than medication or medical procedures, traditional physical side effects are not applicable. However, there may be privacy concerns or stress related to discussing sexual health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of a sexually transmitted infection (STI) testing clinical decision support (CDS) tool among adolescents
Acceptability of a sexually transmitted infection (STI) testing clinical decision support (CDS) tool among clinicians as assessed through qualitative interviews.
Acceptability of a sexually transmitted infection (STI) testing clinical decision support (CDS) tool among parents of adolescents
+2 more
Secondary outcome measures
Assessment of the CDS tool's impact on the number of positive STI/HIV tests.
Assessment of the CDS tool's impact on the number of sexually transmitted infection/human immunodeficiency virus (STI/HIV) tests ordered.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CDS Tool EvaluationExperimental Treatment1 Intervention
All participants will receive intervention and feasibility, acceptability, and usability of intervention will be assessed from each participant cohort group.

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
708 Previous Clinical Trials
8,582,830 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,519 Total Patients Enrolled
Brian P. Jenssen, MDPrincipal InvestigatorPrimary care pediatrician and researcher

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are allowed to partake in this medical experiment?

"Affirmative, the information stored on clinicaltrials.gov states that this research is actively soliciting participants. This trial was initially posted to the website on September 26th 2023 and has since been updated as recently as October 2nd 2023. A total of 250 patient are being sought from a single medical facility."

Answered by AI

Has recruitment commenced for this research study?

"Affirmative, according to the clinicaltrials.gov database this investigation has started recruiting participants since its inauguration on September 26th 2023. The trial is currently looking for 250 people from a single medical site and was last updated on October 2nd 2023."

Answered by AI
~120 spots leftby Apr 2025